School of Pharmacy, University of Health and Allied Sciences, Ho, Ghana.
College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2109365. doi: 10.1080/21645515.2022.2109365. Epub 2022 Aug 10.
This study assessed adverse events following immunizations (AEFIs) reported on COVID-19 vaccines in VigiAccess and determined the reporting trends across all continents of the world. The study was cross-sectional quantitative in design. VigiAccess was searched on 10 November 10 2021 for reported adverse events following the introduction of COVID-19 vaccines. After entering the search term, "COVID-19 vaccines" in VigiAccess, AEFIs associated with nine approved brands of COVID-19 vaccines had been documented in the database. Data were captured among age groups, sex, and continents of the world and analyzed using Statistical Package for Social Sciences (SPSS) version 25. Overall, 2,457,386 AEFIs had been reported in VigiAccess at the time of the search. No causal associations could be established between the vaccines and the AEFIs. The public accessing VigiAccess data should therefore be made aware of this in order to not falsely attribute AEFIs to COVID-19 vaccines when assessing the database.
本研究评估了 VigiAccess 中报告的 COVID-19 疫苗接种后不良事件（AEFIs），并确定了全球各大洲的报告趋势。该研究采用横断面定量设计。于 2021 年 11 月 10 日在 VigiAccess 中搜索 COVID-19 疫苗引入后报告的不良事件后，在数据库中记录了与九种批准的 COVID-19 疫苗品牌相关的 AEFIs。在年龄组、性别和世界各大洲之间捕获数据，并使用社会科学统计软件包（SPSS）版本 25 进行分析。总体而言，在搜索时，VigiAccess 中已报告了 2,457,386 例 AEFIs。不能确定疫苗与 AEFIs 之间存在因果关系。因此，公众在访问 VigiAccess 数据时应注意这一点，以免在评估数据库时将 AEFIs 错误归因于 COVID-19 疫苗。
